This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

BODE index (BMI , airflow obstruction , dyspnoea and exercise capacity)

Authoring team

The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD (1)

The study authors evaluated 207 COPD patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test (1)

  • the authors used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death

0 point

1 point

2 points

3 points

FEV1 (% predicted)

>= 65

50-64

36-49

<= 35

6-Minute Walk Test (meters)

>=350

250-349

150-249

<149

MMRC Dyspnea Scale

0-1

2

3

4

Body Mass Index *

>21

<=21

 

* The Body Mass Index values were correlated as 0 or 1 because of the inflection point in the inverse relationship between survival and a body mass index of 21, ie a Body Mass Index of >21 was associated with greater chance of survival than a BMI of <=21

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.